BioCentury | Oct 20, 2008
Finance

VCs confront the turmoil

...afterwards. It indeed has implications for the profile of the companies which are financed." Still, GLSV's...
BioCentury | Aug 6, 2007
Finance

Ebb & Flow

...million. Venture tracks Global Life Science Ventures promoted Stephen McCormack to managing director from partner. GLSV...
BioCentury | May 7, 2007
Finance

Global visibility

...series B round led by Dietmar Hopp's family investment vehicles; DH Capital; and OH Beteiligungen. Global Life Science Ventures GmbH...
...and others clearly help communicate the potential of life science funds to the LPs," said GLSV...
BioCentury | Nov 13, 2006
Finance

Ebb & Flow

...works in Zug, Switzerland. Reithinger has been at GLSV since 2004 and works in Munich. GLSV...
BioCentury | May 8, 2006
Finance

Ebb & Flow

...was CEO of Timaq Medical Imaging, a CRO. He will be based in Zug, Switzerland. GLSV...
BioCentury | Mar 15, 2006
Financial News

Santaris announces B round

...total EUR 40 million. ABN AMRO led the round. New investors Global Life Science Ventures (GLSV...
...of EUR 19 million will complete within a year. ABN AMRO's Martien van Osch and GLSV's...
BioCentury | Oct 12, 2004
Financial News

Reithinger joins GLSV

Holger Reithinger joined Global Life Science Ventures as principal. Reithinger formerly was director of 3i Germany's healthcare practice. BC Staff...
BioCentury | Oct 4, 2004
Finance

Europe: The news will be light

...by TVM. The company now has about three years of runway, Bert van Toor of GLSV...
BioCentury | Sep 20, 2004
Finance

Ebb & Flow

...will soon invest in an undisclosed European reformulation company, according to Bert van Toor of GLSV...
BioCentury | Jun 21, 2004
Finance

Ebb & Flow

...under management. Global Life Science Ventures appointed Bert van Toor as investment manager in in GLSV's...
...was global project manager and medical director for the Benelux region at Bayer (FSE:BAYG; BAY). GLSV...
Items per page:
1 - 10 of 13
BioCentury | Oct 20, 2008
Finance

VCs confront the turmoil

...afterwards. It indeed has implications for the profile of the companies which are financed." Still, GLSV's...
BioCentury | Aug 6, 2007
Finance

Ebb & Flow

...million. Venture tracks Global Life Science Ventures promoted Stephen McCormack to managing director from partner. GLSV...
BioCentury | May 7, 2007
Finance

Global visibility

...series B round led by Dietmar Hopp's family investment vehicles; DH Capital; and OH Beteiligungen. Global Life Science Ventures GmbH...
...and others clearly help communicate the potential of life science funds to the LPs," said GLSV...
BioCentury | Nov 13, 2006
Finance

Ebb & Flow

...works in Zug, Switzerland. Reithinger has been at GLSV since 2004 and works in Munich. GLSV...
BioCentury | May 8, 2006
Finance

Ebb & Flow

...was CEO of Timaq Medical Imaging, a CRO. He will be based in Zug, Switzerland. GLSV...
BioCentury | Mar 15, 2006
Financial News

Santaris announces B round

...total EUR 40 million. ABN AMRO led the round. New investors Global Life Science Ventures (GLSV...
...of EUR 19 million will complete within a year. ABN AMRO's Martien van Osch and GLSV's...
BioCentury | Oct 12, 2004
Financial News

Reithinger joins GLSV

Holger Reithinger joined Global Life Science Ventures as principal. Reithinger formerly was director of 3i Germany's healthcare practice. BC Staff...
BioCentury | Oct 4, 2004
Finance

Europe: The news will be light

...by TVM. The company now has about three years of runway, Bert van Toor of GLSV...
BioCentury | Sep 20, 2004
Finance

Ebb & Flow

...will soon invest in an undisclosed European reformulation company, according to Bert van Toor of GLSV...
BioCentury | Jun 21, 2004
Finance

Ebb & Flow

...under management. Global Life Science Ventures appointed Bert van Toor as investment manager in in GLSV's...
...was global project manager and medical director for the Benelux region at Bayer (FSE:BAYG; BAY). GLSV...
Items per page:
1 - 10 of 13